Founded in 1985, Livzon Pharma is a dual-listed public company, integrating with R&D, manufacturing and Sales in China. With a 2024 revenue of $1.7B, Livzon focuses on both in- and out- licensing partnership. Please no service provider requests.
Address
ShenzhenGuangdong
China
